Celanese sinks 9% as BMO slashes target to $46 on leverage concerns
Celanese shares fell about 9% to roughly $63 as a fresh bearish analyst move hit sentiment around leverage and earnings durability. BMO Capital cut its price target to $46 from $73 while keeping an Underperform rating after Celanese’s latest quarterly results.
1) What’s moving the stock
Celanese (CE) is sliding sharply in Friday trading, down about 9%, after a notably negative analyst reset that underscored investor sensitivity to leverage and the pace of earnings recovery. BMO Capital lowered its price target to $46 from $73 and reiterated an Underperform rating following the company’s fiscal first-quarter report, pressuring the stock as the market reprices downside scenarios and balance-sheet risk.
2) Why the market is reacting now
With Celanese still viewed through a deleveraging lens, incremental signals from earnings and forward commentary can produce outsized equity moves. The latest target cut reinforces concerns that weaker-than-expected profitability and the time required to reduce debt can cap valuation, particularly if end-market demand remains uneven and free-cash-flow conversion is challenged by the cycle.
3) What to watch next
Investors will focus on (a) evidence that cash generation is trending toward Celanese’s 2026 free-cash-flow target range, (b) any additional portfolio actions that accelerate debt paydown, and (c) whether recent price increases in engineered materials hold without further volume erosion. The next catalyst cluster is likely to be management updates on pricing, volumes in autos/industrial demand, and progress on leverage metrics versus covenant and maturity timelines.